公开(公告)号：EP4389128A1

公开(公告)日：2024-06-26

申请号：EP22858550.1

申请日：2022-08-19

申请人： Otsuka Pharmaceutical Co., Ltd.

发明人： SONE, Masayuki ,  MATSUYAMA, Hironori ,  TAZURU, Keisuke ,  KOGUE, Yosuke ,  AKAMINE, Hiroki ,  SUDO, Toshiki

IPC分类号： A61K31/5377 ,  A61K35/17 ,  A61P35/00 ,  A61P43/00

CPC分类号： A61P43/00 ,  A61K31/5377 ,  A61P35/00 ,  A61K39/4632 ,  A61K39/464488 ,  A61K39/464412 ,  A61K39/4611 ,  A61K2239/3120230501 ,  A61K39/4613 ,  A61K39/4631

摘要： The present invention discloses administering pharmaceutical compositions in combination, one of which is a pharmaceutical composition containing a tolinapant drug, and the other of which is a pharmaceutical composition containing an immune cell modified to express a chimeric antigen receptor or a recombinant T-cell receptor.